Clinical Trial: Safety and Efficacy of Canagliflozin in Patients With Locally Advanced or Advanced Solid Cancer

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07703163) titled 'Safety and Efficacy of Canagliflozin in Patients With Locally Advanced or Advanced Solid Cancer' on June 23.

Brief Summary: **Revised version:**

Locally advanced or advanced solid tumors remain a major clinical challenge despite multimodal treatments, including surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy. For patients with unresectable, recurrent, metastatic, or treatment-refractory disease, prognosis remains poor, and effective therapeutic strategies are still urgently needed. Immune checkpoint inhibitors (ICIs), particularly PD-1/PD-L1 blockade, have transformed the treatment landscape of multiple sol...